Developer docs
API playgroundTry for free, no card

Search company profiles

BioLabs

Full company profile

uuid0004tbw

Namestring
BioLabs
Legal namestring
BioLabs
Websiteurl
biolabs.io
Company typeenum
Private
Founded yearint
2009
Descriptiontext

BioLabs operates a membership-based network of shared laboratory and office facilities designed for early-stage life science companies. Founded in 2009 by Johannes Fruehauf and headquartered in Cambridge, Massachusetts, the company provides fully equipped, turnkey lab infrastructure — including benches, private suites, shared equipment, and operational support — that allows biotech startups to begin experimental work within days rather than months. As of the input period, BioLabs operates 21 sites across five countries (United States, Canada, France, Germany, and Japan) on three continents, housing more than 440 resident companies that have collectively raised over $5 billion in venture capital.

The company's core product is a co-working lab real estate platform differentiated by centralized operations, standardized site design, and a multi-sided business model. BioLabs generates revenue through recurring membership fees paid by resident startups (per-bench and private-suite pricing tiers), supplemented by sponsorship revenue from a network of more than 60 pharmaceutical, biotechnology, and laboratory equipment companies — including AbbVie, Bristol-Myers Squibb, Sanofi, Pfizer, Daiichi Sankyo, Thermo Fisher, and Agilent. Sponsors gain curated access to the resident startup pipeline through programming such as the Golden Ticket award, pitch events, and dedicated innovation programs. Member companies benefit from flexible, low-commitment access to wet-lab infrastructure they could not otherwise afford as standalone facilities.

BioLabs has pursued an aggressive expansion strategy, opening or announcing sites in Philadelphia (March 2025), Paris-Saclay via a joint venture with Servier (June 2025), Berlin with Berlin Institute of Health (July 2025), Vermont (October 2025), Toronto at MaRS Discovery District (April 2026), and Rochester, Minnesota with Mayo Clinic (Fall 2026). These moves extend the network into new therapeutic verticals (advanced therapeutics, cell and gene therapy), new geographies (first Canadian and rural sites), and deeper academic/clinical integration. The platform operates with reported headcount in the 80-250 range depending on source, supporting centralized site operations, sponsorship management, and resident services.

Short descriptiontext

BioLabs operates a 21-site global network of shared laboratory and office facilities serving 440+ life science startups, with revenue from membership fees and a 60+ sponsor roster of major pharma and equipment manufacturers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices20 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
shared laboratory facilities, biotech incubator services, co-working lab spaces, life science coworking, lab equipment access
Industry3 codes
1Bioprocess Facility, Cleanroom & Utility Systems (HVAC, WFI, CIP/SIP, containment)
CodeHLAAAJAJPrimaryYes
2Process Development & Tech Transfer Services (upstream/downstream)
CodeHLAAAKAFPrimaryNo
3Process Development & Tech Transfer (Upstream/Downstream/MSAT)
CodeHLAGAGAEPrimaryNo
NAICS code1 code
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code2 codes
  • Laboratory Apparatus & Furniture3821
  • Services-Commercial Physical & Biological Research8731
Product category
Biotech Incubator Services
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Membership Fees
TypeSubscription Recurring
Description

BioLabs operates as a membership-based network where life science startups pay for access to shared lab facilities, office space, equipment, and the global network. Membership tiers offer varying levels of bench space, private labs, and graduate suites.

biolabs.io
2Sponsorship Revenue
TypeSubscription Recurring
Description

Pharmaceutical companies, biotech firms, and equipment manufacturers pay sponsorship fees for visibility, access to startups, and participation in the Golden Ticket program.

biolabs.io
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Infrastructure, Operations, Personnel, Technology or R&D, Marketing or Sales
Pricing details3 tiers
1Single bench in shared open lab
ModelSubscriptionBilling cadenceMonthly
Notes

Entry-level membership offering shared laboratory bench access

biolabs.io
2Private graduate suites (23-bench)
ModelSubscriptionBilling cadenceMonthly
Notes

Private laboratory space for scaling companies; located at Curtis in Philadelphia

biolabs.io
3Golden Ticket Award
ModelSubscriptionBilling cadenceAnnual
Notes

One year of complimentary membership and dedicated laboratory bench space awarded to competition winners; supported by pharma sponsors

biolabs.io
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1Spartners
Description

A premier biotech incubator located at Servier R&D center in Paris-Saclay, co-founded with Servier. Provides access to state-of-the-art laboratories, modular workspaces, and collaborative environment for startups.

biolabs.io
+2 more records
Core offering1 text field

BioLabs operates an international, membership-based network of shared laboratory and office co-working facilities for life science startups. Members pay recurring subscription fees for access to fully equipped lab bench space, private suites, shared scientific equipment, and operational support services across 21 sites in key biotech innovation clusters worldwide. The company supplements core facility rental with the BioLabs Marketplace procurement platform and the pharma-sponsored Golden Tickets Program offering complimentary membership and mentorship to winning startups.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Member companies have collectively raised over $5B in funding
+5 more records
Product overview1 text field

BioLabs is a membership-based international network of shared laboratory and office facilities for life science startups. The core offering includes fully equipped co-working lab spaces with shared equipment across 21 global locations. Key products and programs include: BioLabs Marketplace (an end-to-end cloud-based procurement platform with access to 1,000+ suppliers), the Golden Tickets Program (sponsored competition awarding free lab space and mentorship, with 50+ awarded globally), and specialized facilities like BioLabs for Advanced Therapeutics in Philadelphia (focused on cell and gene therapy with Thermo Fisher collaboration), BioLabs University of Toronto (first Canadian location in MaRS Discovery District), and Spartners at Paris-Saclay (co-founded with Servier). The network spans 3 continents, 5 countries, and supports over 440 resident companies that have collectively raised more than $5B.

Product and service12 records
1BioLabs Shared Lab & Office Facilities
CategoryCore service - shared lab and office co-working
Description

Membership-based shared laboratory and office co-working facilities for life science startups, providing shared equipment, modular workspaces from single bench to private suites, and collaborative environments in key biotech innovation clusters across the USA, Canada, France, Germany, and Japan.

2BioLabs Marketplace
CategoryProcurement platform
Description

Cloud-based procurement platform enabling BioLabs member companies to purchase research tools and supplies from over 1,000 suppliers with pre-negotiated discounts, dedicated order support, and simplified billing.

3Golden Tickets Program
CategorySponsored award program
Description

Sponsorship competition program where pharma partners select winning biotech startups to receive one year of complimentary BioLabs membership, dedicated laboratory bench access, and mentorship from sponsor scientific leaders.

4BioLabs for Advanced Therapeutics
CategorySpecialized facility - advanced therapeutics
Description

Specialized incubator facility in Philadelphia focused on advanced therapeutics including cell therapy, gene therapy, and related technologies. Features 30,000 sq ft expansion with specialized support labs, process development equipment, and Thermo Fisher's Advanced Therapies Collaboration Center.

5BioLabs University of Toronto
CategorySpecialized facility - Canadian flagship
Description

40,000-square-foot shared laboratory and office facility located in Toronto's MaRS Discovery District, BioLabs' first Canadian location, supporting over 30 early-stage life science startups with access to global investor networks and industry partners.

6Spartners by Servier & BioLabs
CategorySpecialized facility - European joint venture
Description

Premier biotech incubator at Paris-Saclay co-founded with Servier, offering over 110 lab benches across coworking and private spaces. Provides access to Servier's network of 2,000 researchers and world-class scientific resources.

7BioLabs Rochester MN
CategorySpecialized facility - medical district partnership
Description

16,000 sq ft state-of-the-art co-working laboratory facility at Discover Sq. in Rochester's medical district, developed in collaboration with Mayo Clinic to accelerate HealthTech innovation.

8BioLabs Watertown
CategoryRegional facility - Boston/Cambridge area
Description

21,000 sq ft state-of-the-art co-working facility near Boston/Cambridge biotech cluster, MBTA accessible, offering flexible lab and office spaces for biotech startups.

9BioLabs San Diego
CategoryRegional facility - Southern California
Description

Premier co-working space for life science startups in San Diego, co-founded with Biocom, featuring specialized lab and office facilities designed for startups to test, develop, and grow biotech innovations.

10Princeton Innovation Center BioLabs
CategoryRegional facility - Princeton partnership
Description

Co-working environment in New Jersey's academic community, in partnership with Princeton University, offering shared office and lab space with strategic access to capital and industry partners for early-stage life science companies.

11BioLabs Tokyo
CategoryRegional facility - Japan
Description

BioLabs facility at Shinkiba in Tokyo Bay, part of Mitsui Fudosan's R&D hub, established in collaboration with LINK-J to support Japanese life science startups with access to global networks.

12BioLabs Pegasus Park (North Texas)
CategoryRegional facility - North Texas
Description

37,000 sq ft flexible co-working lab and office facilities located on the 23-acre Pegasus Park campus in Dallas, enabling collaboration and entrepreneurship throughout the North Texas area.

Scale indicator23 records

Each record includes

Type, Value, Description, Source

Partnership18 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-04-20
Description

AbbVie is a founding sponsor of BioLabs University of Toronto and has expanded its global partnership with BioLabs across multiple locations. The company sponsors the annual AbbVie Biotech Innovators Awards program providing winning recipients with free lab and office space, shared equipment, and mentorship. AbbVie also sponsors BioLabs Tokyo as founding sponsor and offers the AbbVie Japan Innovation Award Golden Ticket program.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-02-25
Description

University of Toronto partnered with BioLabs to launch Toronto's largest shared lab incubator at MaRS Discovery District. BioLabs took over a life sciences incubator space formerly supported by Johnson & Johnson, ensuring ongoing support for over 30 early-stage startups. This is BioLabs' first Canadian location.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-18
Description

Thermo Fisher opened its second East Coast Advanced Therapies Collaboration Center (ATxCC) within BioLabs for Advanced Therapeutics in Philadelphia. The facility supports cell and gene therapy development by providing lab space, expertise, and collaboration opportunities to biotech and biopharma startups.

Strategic tierFoundingTypeStrategic or Co-development PartnerAnnounced on2025-10-16
Description

Mayo Clinic is the founding partner for BioLabs Rochester MN, coming Fall 2026. The 16,000 sq ft facility at Discover Sq. in the Rochester MN medical district will attract local, regional, and global entrepreneurial innovators seeking connections with Mayo Clinic's world-class scientific and healthcare excellence.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-16
Description

BioLabs launched its first rural site in partnership with University of Vermont, aiming to fuel regional bioscience innovation outside major metropolitan areas.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-07-15
Description

BIH partnered with BioLabs to launch the BIH Clinical Incubator (CLIC) at Rahel Hirsch Center to support research teams and entrepreneurs in developing advanced therapies and personalized medical products. The incubator provides infrastructure, mentorship, and access to BioLabs' global network.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-06-11
Description

Co-founded Spartners by Servier & BioLabs at Paris-Saclay - a premier biotech incubator with over 110 lab benches. Servier provides access to 2,000+ researchers for mentorship and expert coaching. Grand opening celebrated June 11, 2025 after two years of supporting health innovation.

Strategic tierFoundingTypeStrategic or Co-development Partner
Description

Biocom is the founding partner of BioLabs San Diego, co-designing the premier co-working space for life science startups in Southern California.

Strategic tierFoundingTypeStrategic or Co-development Partner
Description

Mitsui Fudosan is developing the R&D hub where BioLabs Tokyo is located in Shinkiba, Tokyo. The partnership provides access to one of Japan's most strategically positioned innovation corridors.

Strategic tierFoundingTypeStrategic or Co-development Partner
Description

LINK-J (Life Science Innovation Network Japan) partners with BioLabs to provide deep industry-government-academia connections for resident companies, bridging Japan's exceptional foundational research with real-world application.

Strategic tierFoundingTypeStrategic or Co-development Partner
Description

Princeton University is the founding partner of Princeton Innovation Center BioLabs, nestled in New Jersey's academic community and part of the broader Princeton innovation ecosystem.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Lundquist Institute is developing a 15-acre biotech park in partnership with Trammell Crow Co. to support companies graduating from its BioLabs incubator at the West Carson, California location.

Strategic tierStrategicTypeChannel Partner/ Reseller/ Distributor
Description

BioLabs partnered with LabCentral for joint Golden Ticket programs in the Boston-Cambridge ecosystem. LabCentral has awarded over 150 Golden Tickets worth $7.5 million since 2017.

Strategic tierStrategicTypeChannel Partner/ Reseller/ Distributor
Description

BioLabs partnered with MBC BioLabs as part of the strategic partnership with AbbVie to boost innovation in key biotech clusters in the US and Europe.

Strategic tierCoreTypeGTM or Marketing Partner
Description

OBIO partnered with BioLabs - University of Toronto for the Entrepreneurship Training Program for Women in STEM, launching March 2026 to support 25-30 female innovators. OBIO also invested $100,000 in Block Biosciences through the WiHI Seed Program.

Strategic tierFoundingTypeStrategic or Co-development Partner
Description

Pegasus Park is the host campus for BioLabs North Texas, providing the 23-acre reinvigorated campus location for the 37,000 sq ft facility.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

BioLabs at Charite in Berlin serves the German life sciences ecosystem through partnership with Charite university hospital.

Strategic tierFoundingTypeStrategic or Co-development Partner
Description

BioLabs at NYU Langone provides incubator space for life science startups in New York City in partnership with NYU Langone Health.

Recent move11 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Johnson & Johnson's global network of life science incubators operating across North America, Europe, and Asia. Larger-scale incumbent with similar no-strings-attached lab space model but tied to J&J's strategic priorities and broader innovation mandate.

TypeRegional player
Description

Toronto-based innovation hub hosting BioLabs' University of Toronto location. Comparable as a multi-tenant life science and tech incubator with shared infrastructure, but operates as a broader tech/life science hub rather than a biotech-only coworking space.

TypeDirect peer
Description

Biotech accelerator providing lab space, programming, and seed funding to biology startups. Direct peer focusing on biology-first companies with an accelerator/program structure layered on top of shared lab infrastructure (NY and SF).

TypeDirect peer
Description

San Carlos, CA-based shared lab and office facility for early-stage life science startups. Direct competitor with similar membership model, partnered with BioLabs through AbbVie for joint Golden Ticket competitions in the Bay Area biotech ecosystem.

TypeRegional player
Description

St. Louis-based nonprofit life science startup accelerator and investor providing lab space, mentorship, and seed funding. Regional competitor with combined incubator/VC model serving a focused geographic market, with similar support services to early-stage biotech founders.

TypeBroad incumbent
Description

Alexandria Real Estate's startup platform providing move-in-ready lab and office space, strategic capital, and operational support to early-stage life science companies. Backed by a major life science REIT, offers deeper real estate integration but less sponsor-pharma ecosystem focus than BioLabs.

TypeRegional player
Description

UK-based innovation center for cell and gene therapy with large-scale manufacturing facilities and similar shared infrastructure model. Comparable to BioLabs' Advanced Therapeutics facility in Philadelphia, but operating in the UK with a more manufacturing-focused mandate.

TypeEmerging player
Description

Global shared workspace and innovation campus operator with growing life science lab offerings (CIC Labs). Comparable coworking/shared infrastructure model expanding into wet lab space, competing in adjacent verticals of the startup ecosystem.

TypeDirect peer
Description

Cambridge, MA-based shared lab incubator for biotech startups, operating across multiple sites in the Kendall Square area. Most direct competitor to BioLabs with the same membership-based coworking model; notably founded by the same individual (Johannes Fruehauf) and operating a partnership/joint Golden Ticket program with BioLabs.

TypeEmerging player
Description

Boston-based biotech accelerator and community platform. Emerging player providing early-stage programming and resources for biology startups, with a smaller physical footprint than BioLabs but overlapping target market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BioLabs

Biotech Incubator Servicesbiolabs.io

BioLabs operates a 21-site global network of shared laboratory and office facilities serving 440+ life science startups, with revenue from membership fees and a 60+ sponsor roster of major pharma and equipment manufacturers.

What BioLabs does

BioLabs operates a membership-based network of shared laboratory and office facilities designed for early-stage life science companies. Founded in 2009 by Johannes Fruehauf and headquartered in Cambridge, Massachusetts, the company provides fully equipped, turnkey lab infrastructure — including benches, private suites, shared equipment, and operational support — that allows biotech startups to begin experimental work within days rather than months. As of the input period, BioLabs operates 21 sites across five countries (United States, Canada, France, Germany, and Japan) on three continents, housing more than 440 resident companies that have collectively raised over $5 billion in venture capital.

The company's core product is a co-working lab real estate platform differentiated by centralized operations, standardized site design, and a multi-sided business model. BioLabs generates revenue through recurring membership fees paid by resident startups (per-bench and private-suite pricing tiers), supplemented by sponsorship revenue from a network of more than 60 pharmaceutical, biotechnology, and laboratory equipment companies — including AbbVie, Bristol-Myers Squibb, Sanofi, Pfizer, Daiichi Sankyo, Thermo Fisher, and Agilent. Sponsors gain curated access to the resident startup pipeline through programming such as the Golden Ticket award, pitch events, and dedicated innovation programs. Member companies benefit from flexible, low-commitment access to wet-lab infrastructure they could not otherwise afford as standalone facilities.

BioLabs has pursued an aggressive expansion strategy, opening or announcing sites in Philadelphia (March 2025), Paris-Saclay via a joint venture with Servier (June 2025), Berlin with Berlin Institute of Health (July 2025), Vermont (October 2025), Toronto at MaRS Discovery District (April 2026), and Rochester, Minnesota with Mayo Clinic (Fall 2026). These moves extend the network into new therapeutic verticals (advanced therapeutics, cell and gene therapy), new geographies (first Canadian and rural sites), and deeper academic/clinical integration. The platform operates with reported headcount in the 80-250 range depending on source, supporting centralized site operations, sponsorship management, and resident services.

BioLabs firmographics

Firmographics
Name
BioLabs
Legal name
BioLabs
Website
https://biolabs.io
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
101–250 employees
Short description
BioLabs operates a 21-site global network of shared laboratory and office facilities serving 440+ life science startups, with revenue from membership fees and a 60+ sponsor roster of major pharma and equipment manufacturers.
Ownership category
akta.pro rank

BioLabs industry classification

Industry
Product category
Biotech Incubator Services
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Laboratory Apparatus & Furniture (3821), Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Bioprocess Facility, Cleanroom & Utility Systems (HVAC, WFI, CIP/SIP, containment) (HLAAAJAJ)
akta.pro secondary industries
Process Development & Tech Transfer Services (upstream/downstream) (HLAAAKAF), Process Development & Tech Transfer (Upstream/Downstream/MSAT) (HLAGAGAE)

Keywords

  • Shared laboratory facilities
  • Biotech incubator services
  • Co-working lab spaces
  • Life science coworking
  • Lab equipment access

Where BioLabs is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices20 records

Markets served

BioLabs business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Infrastructure, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Membership Fees: BioLabs operates as a membership-based network where life science startups pay for access to shared lab facilities, office space, equipment, and the global network. Membership tiers offer varying levels of bench space, private labs, and graduate suites.
  2. Sponsorship Revenue: Pharmaceutical companies, biotech firms, and equipment manufacturers pay sponsorship fees for visibility, access to startups, and participation in the Golden Ticket program.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlySingle bench in shared open lab
SubscriptionMonthlyPrivate graduate suites (23-bench)
SubscriptionAnnualGolden Ticket Award

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

BioLabs product offering

Product offering

Core offering

BioLabs operates an international, membership-based network of shared laboratory and office co-working facilities for life science startups. Members pay recurring subscription fees for access to fully equipped lab bench space, private suites, shared scientific equipment, and operational support services across 21 sites in key biotech innovation clusters worldwide. The company supplements core facility rental with the BioLabs Marketplace procurement platform and the pharma-sponsored Golden Tickets Program offering complimentary membership and mentorship to winning startups.

Product overview

BioLabs is a membership-based international network of shared laboratory and office facilities for life science startups. The core offering includes fully equipped co-working lab spaces with shared equipment across 21 global locations. Key products and programs include: BioLabs Marketplace (an end-to-end cloud-based procurement platform with access to 1,000+ suppliers), the Golden Tickets Program (sponsored competition awarding free lab space and mentorship, with 50+ awarded globally), and specialized facilities like BioLabs for Advanced Therapeutics in Philadelphia (focused on cell and gene therapy with Thermo Fisher collaboration), BioLabs University of Toronto (first Canadian location in MaRS Discovery District), and Spartners at Paris-Saclay (co-founded with Servier). The network spans 3 continents, 5 countries, and supports over 440 resident companies that have collectively raised more than $5B.

Differentiator

Problem solved

Functional benefit

Brands

  • Spartners: A premier biotech incubator located at Servier R&D center in Paris-Saclay, co-founded with Servier. Provides access to state-of-the-art laboratories, modular workspaces, and collaborative environment for startups.
  • BioLabs Marketplace
  • Golden Tickets

Products and services

  • BioLabs Shared Lab & Office Facilities Membership-based shared laboratory and office co-working facilities for life science startups, providing shared equipment, modular workspaces from single bench to private suites, and collaborative environments in key biotech innovation clusters across the USA, Canada, France, Germany, and Japan.
  • BioLabs Marketplace Cloud-based procurement platform enabling BioLabs member companies to purchase research tools and supplies from over 1,000 suppliers with pre-negotiated discounts, dedicated order support, and simplified billing.
  • Golden Tickets Program Sponsorship competition program where pharma partners select winning biotech startups to receive one year of complimentary BioLabs membership, dedicated laboratory bench access, and mentorship from sponsor scientific leaders.
  • BioLabs for Advanced Therapeutics Specialized incubator facility in Philadelphia focused on advanced therapeutics including cell therapy, gene therapy, and related technologies. Features 30,000 sq ft expansion with specialized support labs, process development equipment, and Thermo Fisher's Advanced Therapies Collaboration Center.
  • BioLabs University of Toronto 40,000-square-foot shared laboratory and office facility located in Toronto's MaRS Discovery District, BioLabs' first Canadian location, supporting over 30 early-stage life science startups with access to global investor networks and industry partners.
  • Spartners by Servier & BioLabs Premier biotech incubator at Paris-Saclay co-founded with Servier, offering over 110 lab benches across coworking and private spaces. Provides access to Servier's network of 2,000 researchers and world-class scientific resources.
  • BioLabs Rochester MN 16,000 sq ft state-of-the-art co-working laboratory facility at Discover Sq. in Rochester's medical district, developed in collaboration with Mayo Clinic to accelerate HealthTech innovation.
  • BioLabs Watertown 21,000 sq ft state-of-the-art co-working facility near Boston/Cambridge biotech cluster, MBTA accessible, offering flexible lab and office spaces for biotech startups.
  • BioLabs San Diego Premier co-working space for life science startups in San Diego, co-founded with Biocom, featuring specialized lab and office facilities designed for startups to test, develop, and grow biotech innovations.
  • Princeton Innovation Center BioLabs Co-working environment in New Jersey's academic community, in partnership with Princeton University, offering shared office and lab space with strategic access to capital and industry partners for early-stage life science companies.
  • BioLabs Tokyo BioLabs facility at Shinkiba in Tokyo Bay, part of Mitsui Fudosan's R&D hub, established in collaboration with LINK-J to support Japanese life science startups with access to global networks.
  • BioLabs Pegasus Park (North Texas) 37,000 sq ft flexible co-working lab and office facilities located on the 23-acre Pegasus Park campus in Dallas, enabling collaboration and entrepreneurship throughout the North Texas area.

Quantifiable outcome

  • Member companies have collectively raised over $5B in funding
  • +5 more outcomes

Companies that use BioLabs

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles4 records

BioLabs technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

BioLabs partnerships and signals

Strategic signal

Partnerships

18 partnerships are on record, tiered flagship, core, founding and strategic.

  • AbbVieflagshipStrategic or Co-development Partner · 20 April 2026AbbVie is a founding sponsor of BioLabs University of Toronto and has expanded its global partnership with BioLabs across multiple locations. The company sponsors the annual AbbVie Biotech Innovators Awards program providing winning recipients with free lab and office space, shared equipment, and mentorship. AbbVie also sponsors BioLabs Tokyo as founding sponsor and offers the AbbVie Japan Innovation Award Golden Ticket program.
  • University of TorontoflagshipStrategic or Co-development Partner · 25 February 2026University of Toronto partnered with BioLabs to launch Toronto's largest shared lab incubator at MaRS Discovery District. BioLabs took over a life sciences incubator space formerly supported by Johnson & Johnson, ensuring ongoing support for over 30 early-stage startups. This is BioLabs' first Canadian location.
  • Thermo Fisher ScientificcoreStrategic or Co-development Partner · 18 November 2025Thermo Fisher opened its second East Coast Advanced Therapies Collaboration Center (ATxCC) within BioLabs for Advanced Therapeutics in Philadelphia. The facility supports cell and gene therapy development by providing lab space, expertise, and collaboration opportunities to biotech and biopharma startups.
  • Mayo ClinicfoundingStrategic or Co-development Partner · 16 October 2025Mayo Clinic is the founding partner for BioLabs Rochester MN, coming Fall 2026. The 16,000 sq ft facility at Discover Sq. in the Rochester MN medical district will attract local, regional, and global entrepreneurial innovators seeking connections with Mayo Clinic's world-class scientific and healthcare excellence.
  • University of VermontcoreStrategic or Co-development Partner · 16 October 2025BioLabs launched its first rural site in partnership with University of Vermont, aiming to fuel regional bioscience innovation outside major metropolitan areas.
  • Berlin Institute of Health (BIH)coreStrategic or Co-development Partner · 15 July 2025BIH partnered with BioLabs to launch the BIH Clinical Incubator (CLIC) at Rahel Hirsch Center to support research teams and entrepreneurs in developing advanced therapies and personalized medical products. The incubator provides infrastructure, mentorship, and access to BioLabs' global network.
  • ServierflagshipStrategic or Co-development Partner · 11 June 2024Co-founded Spartners by Servier & BioLabs at Paris-Saclay - a premier biotech incubator with over 110 lab benches. Servier provides access to 2,000+ researchers for mentorship and expert coaching. Grand opening celebrated June 11, 2025 after two years of supporting health innovation.
  • BiocomfoundingStrategic or Co-development PartnerBiocom is the founding partner of BioLabs San Diego, co-designing the premier co-working space for life science startups in Southern California.
  • Mitsui FudosanfoundingStrategic or Co-development PartnerMitsui Fudosan is developing the R&D hub where BioLabs Tokyo is located in Shinkiba, Tokyo. The partnership provides access to one of Japan's most strategically positioned innovation corridors.
  • LINK-JfoundingStrategic or Co-development PartnerLINK-J (Life Science Innovation Network Japan) partners with BioLabs to provide deep industry-government-academia connections for resident companies, bridging Japan's exceptional foundational research with real-world application.
  • Princeton UniversityfoundingStrategic or Co-development PartnerPrinceton University is the founding partner of Princeton Innovation Center BioLabs, nestled in New Jersey's academic community and part of the broader Princeton innovation ecosystem.
  • Lundquist Institute for Biomedical InnovationcoreStrategic or Co-development PartnerLundquist Institute is developing a 15-acre biotech park in partnership with Trammell Crow Co. to support companies graduating from its BioLabs incubator at the West Carson, California location.
  • LabCentralstrategicChannel Partner/ Reseller/ DistributorBioLabs partnered with LabCentral for joint Golden Ticket programs in the Boston-Cambridge ecosystem. LabCentral has awarded over 150 Golden Tickets worth $7.5 million since 2017.
  • MBC BioLabsstrategicChannel Partner/ Reseller/ DistributorBioLabs partnered with MBC BioLabs as part of the strategic partnership with AbbVie to boost innovation in key biotech clusters in the US and Europe.
  • OBIO (Ontario Bioscience Innovation Organization)coreGTM or Marketing PartnerOBIO partnered with BioLabs - University of Toronto for the Entrepreneurship Training Program for Women in STEM, launching March 2026 to support 25-30 female innovators. OBIO also invested $100,000 in Block Biosciences through the WiHI Seed Program.
  • Pegasus ParkfoundingStrategic or Co-development PartnerPegasus Park is the host campus for BioLabs North Texas, providing the 23-acre reinvigorated campus location for the 37,000 sq ft facility.
  • Charite (Berlin)coreStrategic or Co-development PartnerBioLabs at Charite in Berlin serves the German life sciences ecosystem through partnership with Charite university hospital.
  • NYU Langone HealthfoundingStrategic or Co-development PartnerBioLabs at NYU Langone provides incubator space for life science startups in New York City in partnership with NYU Langone Health.

Scale indicators23 records

Recent moves11 records

Expansion highlights5 records

BioLabs competitors and assessment

Company assessment

Broad incumbents

  • JLABS (Johnson & Johnson Innovation): Johnson & Johnson's global network of life science incubators operating across North America, Europe, and Asia. Larger-scale incumbent with similar no-strings-attached lab space model but tied to J&J's strategic priorities and broader innovation mandate.
  • Alexandria LaunchLabs: Alexandria Real Estate's startup platform providing move-in-ready lab and office space, strategic capital, and operational support to early-stage life science companies. Backed by a major life science REIT, offers deeper real estate integration but less sponsor-pharma ecosystem focus than BioLabs.

Regional players

  • MaRS Discovery District: Toronto-based innovation hub hosting BioLabs' University of Toronto location. Comparable as a multi-tenant life science and tech incubator with shared infrastructure, but operates as a broader tech/life science hub rather than a biotech-only coworking space.
  • BioGenerator: St. Louis-based nonprofit life science startup accelerator and investor providing lab space, mentorship, and seed funding. Regional competitor with combined incubator/VC model serving a focused geographic market, with similar support services to early-stage biotech founders.
  • CELL AND GENE THERAPY CATAPULT: UK-based innovation center for cell and gene therapy with large-scale manufacturing facilities and similar shared infrastructure model. Comparable to BioLabs' Advanced Therapeutics facility in Philadelphia, but operating in the UK with a more manufacturing-focused mandate.

Direct peers

  • IndieBio: Biotech accelerator providing lab space, programming, and seed funding to biology startups. Direct peer focusing on biology-first companies with an accelerator/program structure layered on top of shared lab infrastructure (NY and SF).
  • MBC BioLabs: San Carlos, CA-based shared lab and office facility for early-stage life science startups. Direct competitor with similar membership model, partnered with BioLabs through AbbVie for joint Golden Ticket competitions in the Bay Area biotech ecosystem.
  • LabCentral: Cambridge, MA-based shared lab incubator for biotech startups, operating across multiple sites in the Kendall Square area. Most direct competitor to BioLabs with the same membership-based coworking model; notably founded by the same individual (Johannes Fruehauf) and operating a partnership/joint Golden Ticket program with BioLabs.

Emerging players

  • CIC (Cambridge Innovation Center): Global shared workspace and innovation campus operator with growing life science lab offerings (CIC Labs). Comparable coworking/shared infrastructure model expanding into wet lab space, competing in adjacent verticals of the startup ecosystem.
  • Petri (Biology-focused accelerator): Boston-based biotech accelerator and community platform. Emerging player providing early-stage programming and resources for biology startups, with a smaller physical footprint than BioLabs but overlapping target market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

BioLabs social profiles

Digital presence

BioLabs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BioLabs leadership team

Management profile

Number of profiles

Profiles10 records

BioLabs funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BioLabs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioLabs

What does BioLabs do?

BioLabs operates an international, membership-based network of shared laboratory and office co-working facilities for life science startups. Members pay recurring subscription fees for access to fully equipped lab bench space, private suites, shared scientific equipment, and operational support services across 21 sites in key biotech innovation clusters worldwide. The company supplements core facility rental with the BioLabs Marketplace procurement platform and the pharma-sponsored Golden Tickets Program offering complimentary membership and mentorship to winning startups.

Is BioLabs a public or private company?

BioLabs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was BioLabs founded?

BioLabs was founded in 2009. It employs 101 to 250 people.

Where is BioLabs based?

BioLabs is headquartered in San Diego, United States, in the North America region.

How does BioLabs make money?

Two revenue lines are on record. Membership Fees are the primary driver. The others are sponsorship Revenue.

Who are BioLabs's main competitors?

Broad incumbents on record are JLABS (Johnson & Johnson Innovation) and Alexandria LaunchLabs. Regional players are MaRS Discovery District, BioGenerator and CELL AND GENE THERAPY CATAPULT. Direct peers are IndieBio, MBC BioLabs and LabCentral. Emerging players are CIC (Cambridge Innovation Center) and Petri (Biology-focused accelerator).

Does BioLabs have an API?

No public API is recorded for BioLabs.

What industry is BioLabs in?

BioLabs's product category is Biotech Incubator Services. Its primary akta.pro industry code is HLAAAJAJ, Bioprocess Facility, Cleanroom & Utility Systems (HVAC, WFI, CIP/SIP, containment), with a secondary code of HLAAAKAF, Process Development & Tech Transfer Services (upstream/downstream). Its NAICS code is 54171 and its SIC code is 3821.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooAbbVie and BioLabs University of Toronto Open Applications for AbbVie Biotech Innovators Award at Life Sciences Ontario ForumAbbVie and BioLabs University of Toronto opened applications for the AbbVie Biotech Innovators Award at the Life Sciences Ontario Ideas to Action Forum. Two winning companies will each receive a year of free lab space, equipment access, and mentorship. Applications are accepted through November 10, 2026.Mirage NewsBioLabs Rochester MN Gears Up for September LaunchBioLabs Rochester, MN is preparing for a September opening, with leadership in place and recruitment underway for early-stage biotech and health tech companies. The 17,000-square-foot facility, built with Mayo Clinic and partners, will support startups developing diagnostics, therapeutics, and digital health. Applications are now open for the inaugural cohort.BioSpaceAbbVie and BioLabs Team Up to Support Life Sciences Innovation in CanadaAbbVie announced a partnership expansion with BioLabs by becoming the founding sponsor of the new BioLabs University of Toronto facility, supporting biotech startups and innovation in the Ontario life sciences sector. The collaboration aims to accelerate research and translate scientific insights into health solutions, benefiting Canadian entrepreneurs and the local ecosystem.NewswireAbbVie and BioLabs Team Up to Support Life Sciences Innovation in CanadaAbbVie announced its founding sponsorship of BioLabs University of Toronto, expanding its global partnership to support Canadian life sciences innovation. The new 40,000-square-foot facility in Toronto's MaRS Discovery District will support up to 30 early-stage biotech startups, with AbbVie offering mentorship and the annual AbbVie Biotech Innovators Awards.MarketScreenerAbbVie Sponsors New BioLabs Facility in TorontoAbbVie agreed to become the founding sponsor of BioLabs University of Toronto, sponsoring a new 40,000-square-foot lab and office facility. The facility will support up to 30 early-stage biotech startups, and AbbVie will offer an annual innovators award with mentorship and space.YahooAbbVie and BioLabs Team Up to Support Life Sciences Innovation in CanadaAbbVie announced it has become the founding sponsor of BioLabs University of Toronto, a new 40,000-square-foot shared laboratory and office facility located in Toronto's MaRS Discovery District designed to support Canadian life sciences entrepreneurs. The partnership expands AbbVie's existing worldwide collaboration with BioLabs to foster biotech innovation, with AbbVie also launching the annual AbbVie Biotech Innovators Awards program that will provide one recipient with one year of free lab and office space, shared equipment, and mentorship from AbbVie's scientific and business leaders. The facility will support up to 30 early-stage biotechnology startups and aims to strengthen Canada's rapidly growing life sciences sector while advancing Ontario's goal of becoming a biomanufacturing and life sciences hub.NewswireToronto Health Innovation Week Brings Global Capital, Clinical Leaders and Hundreds of Startups to Canada's Largest Health HubToronto Health Innovation Week takes place April 20-24, 2026, bringing together investors, researchers, founders and healthcare leaders for a series of events showcasing Canada's life sciences, biotech and medtech capabilities, including the grand opening of BioLabs University of Toronto and the Bloom Burton & Co. Health Investment Conference. The timing is notable as Canada's life sciences sector achieved the strongest 10-year returns in Canadian venture capital in 2024, yet faces tightened early-stage funding, while Ontario hospitals simultaneously confront a projected $1.8B working capital deficit this fiscal year. BDC announced a new $150M Life Sciences Venture Fund aimed at strengthening Canada's life sciences ecosystem and economic sovereignty through the event.BetaKitU of T taps BioLabs to take over incubator after Johnson & Johnson pulls supportThe University of Toronto has partnered with Cambridge, Massachusetts-based BioLabs to take over and operate the 40,000-square-foot life sciences incubator space that Johnson & Johnson is vacating at MaRS Discovery District, marking BioLabs' first location in Canada. The new BioLabs University of Toronto will ensure that more than 30 existing early-stage life science startups can continue accessing the shared lab equipment and resources, while gaining expanded access to BioLabs' global network of sponsors and investors. BioLabs founder and CEO Johannes Fruehauf stated that the partnership is expected to become a magnet for world-class biotech companies and stimulate job growth in the Toronto innovation ecosystem.UtorontoU of T partners with BioLabs to launch the city’s largest wet-lab incubator and co-working spaceThe University of Toronto has partnered with BioLabs, a global innovation infrastructure company based in Cambridge, Massachusetts, to launch Toronto's largest shared lab incubator at the MaRS Discovery District. The 40,000-square-foot facility, BioLabs' first Canadian location, will support over 30 early-stage life-science startups and provide access to global investor networks, industry partners, and entrepreneurial programming. University officials say the partnership addresses a critical shortage of wet-lab space in downtown Toronto while aiming to keep Canadian research discoveries and talent within the Canadian economy.LA Business JournalLos Angeles Business JournalThe Lundquist Institute for Biomedical Innovation in West Carson, California, is adapting to funding challenges from the National Institutes of Health under the Trump administration by seeking alternative financing sources. The institute received nearly $70 million in NIH grants in 2024 but has faced delays or rejections on grant applications, particularly for vaccine studies and population research, prompting researchers to refocus proposals and pursue private foundations and state funding. The institute is also advancing long-term plans including a 15-acre biotech park developed in partnership with Trammell Crow Co. to support companies graduating from its BioLabs incubator.